Page last updated: 2024-08-17

levodopa and Catatonia

levodopa has been researched along with Catatonia in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19907 (58.33)18.7374
1990's1 (8.33)18.2507
2000's3 (25.00)29.6817
2010's1 (8.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arai, H; Hatta, K; Hattori, N; Ishikawa, K; Kamigaichi, R; Kubo, S; Mochizuki, H; Ogaki, K; Usui, C; Yokoyama, K1
Aguilar-Venegas, LC; Espinola-Nadurille, M; Fricchione, GL; Merida-Puga, J; Ramirez-Bermudez, J1
Ichinose, H; Ihara, M; Ikeda, A; Kawamoto, Y; Kohara, N; Nishida, T; Saiki, H; Shibasaki, H; Takagi, S; Takao, S; Urano, F1
Kulkarni, SK; Singh, A1
West, AP1
Luther, JS; Stoudemire, A1
Jain, NK; Jain, SK; Rana, AC1
Chrétien, M; Motomatsu, T; Seidah, N1
Boucher, R; Dankova, J; Larochelle, L; Péchadre, JC; Poirier, LJ1
Neppe, VM1
Patterson, JF1
Bartholini, G; Bigler, R; Brossi, A; Burns, JJ; Kaiser, A; Pletscher, A; Pool, W; Sheppard, H1

Other Studies

12 other study(ies) available for levodopa and Catatonia

ArticleYear
Effective control of catatonia in Parkinson's disease by electroconvulsive therapy: a case report.
    European journal of neurology, 2009, Volume: 16, Issue:2

    Topics: Aged; Antiparkinson Agents; Azepines; Benzothiazoles; Cabergoline; Carbidopa; Catatonia; Catechols; Drug Therapy, Combination; Electroconvulsive Therapy; Ergolines; Female; Humans; Levodopa; Nitriles; Parkinson Disease; Pramipexole

2009
Westphal variant Huntington disease and refractory catatonia: a case report.
    Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology, 2011, Volume: 24, Issue:4

    Topics: Adult; Amantadine; Carbidopa; Catatonia; Combined Modality Therapy; Dopamine Agents; Drug Combinations; Drug Resistance; Electroconvulsive Therapy; Female; Humans; Huntington Disease; Levodopa

2011
Neuroleptic malignant syndrome with prolonged catatonia in a dopa-responsive dystonia patient.
    Neurology, 2002, Oct-08, Volume: 59, Issue:7

    Topics: Adult; Catatonia; Dystonia; Electroencephalography; Female; GTP Cyclohydrolase; Humans; Levodopa; Neuroleptic Malignant Syndrome

2002
Role of adenosine in drug-induced catatonia in mice.
    Indian journal of experimental biology, 2002, Volume: 40, Issue:8

    Topics: Adenosine; Animals; Antiparkinson Agents; Brain; Carbidopa; Catatonia; Catechol O-Methyltransferase Inhibitors; Catechols; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Injections, Intraperitoneal; Levodopa; Male; Mice; Motor Activity; Perphenazine

2002
Treatments for neuroleptic malignant syndrome.
    The Journal of clinical psychiatry, 1984, Volume: 45, Issue:3

    Topics: Adult; Amantadine; Antipsychotic Agents; Bromocriptine; Catatonia; Electroconvulsive Therapy; Fever; Humans; Levodopa; Male

1984
Neuroleptic malignant syndrome and neuroleptic-induced catatonia: differential diagnosis and treatment.
    International journal of psychiatry in medicine, 1984, Volume: 14, Issue:1

    Topics: Aged; Antipsychotic Agents; Basal Ganglia Diseases; Carbidopa; Catatonia; Diagnosis, Differential; Female; Haloperidol; Humans; Levodopa; Syndrome; Trihexyphenidyl

1984
Brain drug delivery system bearing dopamine hydrochloride for effective management of parkinsonism.
    Drug development and industrial pharmacy, 1998, Volume: 24, Issue:7

    Topics: Animals; Antiparkinson Agents; Brain; Catatonia; Dopamine; Drug Delivery Systems; Levodopa; Liposomes; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley

1998
Cataleptic effect of 61-91 beta-lipotropic hormone in rat.
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1977, Volume: 4, Issue:1

    Topics: 5-Hydroxytryptophan; Animals; beta-Lipotropin; Catalepsy; Catatonia; Dose-Response Relationship, Drug; Humans; Levodopa; Naloxone; Rats; Sheep; Tremor

1977
Stereotaxic lesions and movement disorders in monkeys.
    Advances in neurology, 1975, Volume: 10

    Topics: Animals; Brain; Brain Mapping; Butyrophenones; Catalepsy; Catatonia; Cerebellum; Chorea; Haplorhini; Humans; Hypothalamus, Posterior; Levodopa; Mesencephalon; Methyltyrosines; Monoamine Oxidase Inhibitors; Motor Cortex; Movement Disorders; Parasympatholytics; Phenothiazines; Pons; Reserpine; Stereotaxic Techniques; Substantia Nigra; Tremor

1975
Management of catatonic stupor with L-dopa.
    Clinical neuropharmacology, 1988, Volume: 11, Issue:1

    Topics: Antipsychotic Agents; Catatonia; Humans; Levodopa; Psychotic Disorders

1988
Akinetic parkinsonism and the catatonic syndrome: an overview.
    Southern medical journal, 1986, Volume: 79, Issue:6

    Topics: Adult; Akinetic Mutism; Benztropine; Carbidopa; Catatonia; Humans; Levodopa; Male; Parasympatholytics; Parkinson Disease; Syndrome

1986
L-DOPA: chemical modifications and biological evaluation.
    Advances in neurology, 1974, Volume: 5

    Topics: Animals; Antiparkinson Agents; Blepharoptosis; Catatonia; Disease Models, Animal; Humans; Hypothermia; Levodopa; Male; Mice; Oxotremorine; Parkinson Disease; Reserpine; Structure-Activity Relationship; Tremor

1974